{"podcast":{"title":"California News Today | 2 Min News | The Daily News Now!","slug":"california-news-today-2-min-news-the-daily-news-now-7610473","podcast_index_feed_id":7610473,"rss_url":"https://feeds.fastcast.ai/california-news-today-2-min-news-the-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/california-news-today-2-min-news-the-daily-news-now.jpg","author":"The Daily News Now!","episode_count":2000,"summary":"Hosted by Corey with the Story, California News Today delivers fast, focused daily updates on the stories shaping California—from statewide politics and business to culture, sports, and major local developments. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—bringing local and regional news to every market in the world and keeping communities connected. California News Today is your daily snapshot of what’s happening across the state. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-09-19T10:20:37.087293+00:00","page_url":"https://stenobird.com/podcast/california-news-today-2-min-news-the-daily-news-now-7610473"},"episode":{"title":"FDA Approves New Lung Cancer Immunotherapy | California News","slug":"fda-approves-new-lung-cancer-immunotherapy-california-news","published_at":"2026-09-05T11:27:51+00:00","page_url":"https://stenobird.com/podcast/california-news-today-2-min-news-the-daily-news-now-7610473/fda-approves-new-lung-cancer-immunotherapy-california-news","show_page_url":"https://stenobird.com/podcast/california-news-today-2-min-news-the-daily-news-now-7610473","url":"https://sources.thednn.ai/038a3dc1939f5b6a","audio_url":"https://api.fastcast.ai/audio/c9463e78-351f-4888-9f31-11803defb957.mp3","summary":"FDA just approved a groundbreaking immunotherapy drug for a specific type of lung cancer, marking a major leap in personalized medicine. Targeting a key genetic mutation in non-small cell lung cancers, the treatment shrinks tumors and extends progression-free survival—giving patients longer, healthier lives. Backed by robust clinical trial data, this approval offers renewed hope for patients and families battling one of medicine’s toughest cancers. It also reinforces the critical role of genetic testing in unlocking next-gen therapies—and hints at even bigger breakthroughs ahead. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/038a3dc1939f5b6a","meta_description":"FDA just approved a groundbreaking immunotherapy drug for a specific type of lung cancer, marking a major leap in personalized medicine. Targeting a key g…","key_points":[],"chapters":[],"topics":[],"duration_seconds":98,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/california-news-today-2-min-news-the-daily-news-now-7610473/episodes/fda-approves-new-lung-cancer-immunotherapy-california-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/california-news-today-2-min-news-the-daily-news-now-7610473/fda-approves-new-lung-cancer-immunotherapy-california-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}